The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Sarepta Therapeutics Inc shares valued at $93,550 were sold by Boor Kathryn Jean on Mar 11 ’24. At $122.93 per share, Boor Kathryn Jean sold 761 shares. The insider’s holdings dropped to 7,516 shares worth approximately $0.94 million following the completion of this transaction.
Also, Wigzell Hans Lennart Rudolf sold 15,000 shares, netting a total of over 1,848,795 in proceeds. Following the sale of shares at $123.25 each, the insider now holds 22,840 shares.
Before that, Mayo Stephen had sold 3,135 shares from its account. In a trade valued at $385,480, the Director traded Sarepta Therapeutics Inc shares for $122.96 each. Upon closing the transaction, the insider’s holdings decreased to 3,135 shares, worth approximately $0.82 million.
As published in their initiating research note from BMO Capital Markets on January 31, 2024, Sarepta Therapeutics Inc [SRPT] has been an Outperform and the price target has been revised to $170. As of December 12, 2023, Deutsche Bank has initiated its “Buy” rating for SRPT. Earlier on November 21, 2023, Wedbush initiated its rating. Their recommendation was “an Outperform” for SRPT stock.
Analyzing SRPT Stock Performance
During the last five days, there has been a drop of approximately -1.07%. Over the course of the year, Sarepta Therapeutics Inc shares have jumped approximately 29.06%. Shares of the company reached a 52-week high of $143.00 on 02/16/24 and a 52-week low of $91.34 on 01/05/24. A 50-day SMA is recorded $126.98, while a 200-day SMA reached $111.10. Nevertheless, trading volume fell to 0.62 million shares from 0.29 million shares the previous day.
Support And Resistance Levels for Sarepta Therapeutics Inc (SRPT)
According to the 24-hour chart, there is a support level at 122.74, which, if violated, would cause prices to drop to 121.02. In the upper region, resistance lies at 126.83. The next price resistance is at 129.21. RSI (Relative Strength Index) is 44.84 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.35, which suggests the price will decrease in the coming days. Percent R is at 86.47%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
Is Sarepta Therapeutics Inc subject to short interest?
Stocks of Sarepta Therapeutics Inc saw a sharp rise in short interest on Mar 15, 2024 jumping by 0.16 million shares to 4.97 million. Data from Yahoo Finance shows that the short interest on Feb 15, 2024 was 4.81 million shares. A jump of 3.22% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 4.69 of the overall float, the days-to-cover ratio (short ratio) jumped to 4.69.
